Search - tctmd.com

Displaying 81 - 100 of 501

Sort: Relevancy | Date

Presentation TVT 2023

SPOTLIGHT INNOVATION LECTURE: The CEP Paradox: Reconciling Clinical Evidence, Patient’s Expectations and Future Technological Developments

Presenter: Giora Weisz

June 10, 2023

Presentation TVT 2023

Performance of the New Generation Emboliner Embolic Protection Device for TAVI: the SafePass 3 Study

Presenter: Tamim Nazif

June 09, 2023

Presentation TVT 2023

Novel Use of Left Atrial Appendage Closure (LAAC) Device for Embolic Protection in Ascending Aorta

Presenter: Bridget Lee

June 08, 2023

Presentation TVT 2023

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

Presenter: Samir Kapadia

June 08, 2023

Presentation TVT 2023

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Presenter: Tamim Nazif

June 07, 2023

News Conference News LINC 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

L.A. McKeown

June 06, 2023

News Conference News EuroPCR 2023

Flushing TAVI Valves With Carbon Dioxide May Protect Against Brain Injury

Todd Neale

May 16, 2023

News Daily News

Post-TAVI Stroke More Often Noted at Specialized Centers

Todd Neale

January 31, 2023

News Conference News ISET 2023

Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine

Caitlin E. Cox

January 26, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2022

Shelley Wood

October 31, 2022

News Features

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Todd Neale

October 17, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2022

Shelley Wood

October 03, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

Presentation TCT 2022

TCT 333: Effect of stroke on readmissions and cardiovascularoutcomes in patients with Mitraclip.

Presenter: Nirav Patel

September 19, 2022

Presentation TCT 2022

TCT 332: Clinical outcome of transcatheter aortic valve replacement with TriGUARD 3™ cerebral embolic protection device

Presenter: Sayonara Daal

September 19, 2022

Presentation TCT 2022

TCT 331: Predictors of Valvular and Perivalvular Thrombosis and Relations of Neurological Outcomes after TAVR: ADAPT-TAVR Substudy

Presenter: Yeonwoo Choi

September 19, 2022

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Advertisement

SPOTLIGHT INNOVATION LECTURE: The CEP Paradox: Reconciling Clinical Evidence, Patient’s Expectations and Future Technological Developments

Performance of the New Generation Emboliner Embolic Protection Device for TAVI: the SafePass 3 Study

Novel Use of Left Atrial Appendage Closure (LAAC) Device for Embolic Protection in Ascending Aorta

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

Flushing TAVI Valves With Carbon Dioxide May Protect Against Brain Injury

Post-TAVI Stroke More Often Noted at Specialized Centers

Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine

Top Structural Heart News of 2022

The Biggest News of 2022: TCTMD’s Top 10

TCTMD’s Top 10 Most Popular Stories for October 2022

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

TCTMD’s Top 10 Most Popular Stories for September 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

TCT 333: Effect of stroke on readmissions and cardiovascularoutcomes in patients with Mitraclip.

TCT 332: Clinical outcome of transcatheter aortic valve replacement with TriGUARD 3™ cerebral embolic protection device

TCT 331: Predictors of Valvular and Perivalvular Thrombosis and Relations of Neurological Outcomes after TAVR: ADAPT-TAVR Substudy

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content